US4465693AExpiredUtility
Intravenously administered emulsion from a lecithin base and method of preparation
Est. expiryDec 3, 1999(expired)· nominal 20-yr term from priority
A61K 47/24A61K 9/0019A23J 7/00C09K 23/14
41
PatentIndex Score
11
Cited by
1
References
4
Claims
Abstract
An emulsifier from lecithin base prepared by solvent extraction can be used for intravenous administration. The lecithin base is obtained by filtering or centrifuging, subjecting a solution of a starting lecithin which is soluble in alcohol, in a mixture of alcohol and water, with a defined alcohol:water ratio, to solvent fractionation. Glycerine and soya oil are added to form the emulsion.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A method of intravenous treatment comprising the intravenous administration to a host of an emulsion from lecithin base having the following physico-chemical parameters: (1) ratio between Pc and Pe from 7:3 to 6:1, preferably 4:1, (2) Pc content from 65 to 85% by weight, preferably from 75 to 80% by weight, (3) residual fat content less than 2%, (4) pyrogen-free in the rabbit test according to the European Pharmacopoeia (1975), vol. 2, page 56 et seq., (5) clearly soluble in ethanol at 5% concentration, (6) clearly soluble in chloroform at 10% concentration, (7) maximum water content 2.5%, preferred maximum 1%, (8) maximum peroxide number 5, preferred maximum 1 (determined according to the DGF standard method F-1 3b (68).
2. Method of providing lecithin intravenously into the human body comprising the steps of: (a) preparing a distilled water lecithin dispersion by treating a phospholipid mixture which contains phosphatidylcholine (Pc) and phosphatidylethanolamine (Pe) dissolved in alcohol with sufficient water to cause the partial precipitation of undissolved components of the phospholipid mixture; (b) heating glycerine and refined soya oil separately; (c) adding the heated glycerine to the lecithin water dispersion; (d) adding the soya oil by intense stirring; (e) homogenizing the resulting mixture; (f) decanting the emulsion; (g) and then sterilizing and administering intravenously.
3. Method of claim 2, wherein the lecithin dispersion is 1-2% of the total mixture.
4. Method of claim 2, wherein the refined soya oil added is between 10 and 20%.Join the waitlist — get patent alerts
Track US4465693A — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.